Please read this leaflet carefully before you start using TRELEGY ELLIPTA. This leaflet answers some common questions about TRELEGY ELLIPTA. It does not contain all the available information.

The biotech industry offers a compelling investment opportunity due to its potential for disruptive innovations and high ...

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...

But while topline results, published in May, suggest its new drug Relvar Ellipta is a step forward in treatment, the full trial data paints a more down-to-earth reality – with some disappointing ...